Anti-VEGF biologics (Envisia Therapeutics)

N/A

Report date: 2025/03/14 16:29:14
NME

Base Information

Drug NameAnti-VEGF biologics (Envisia Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnvisia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnvisia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A